Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Caredx Inc (NQ: CDNA )

8.130 +0.120 (+1.50%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 2, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Caredx Inc

< Previous 1 2 3 4 5 6 7 Next >
CareDx Committed to Delivering Clinical Innovation to the Transplant Patient and Physician Community
From CareDx, Inc.
Via Business Wire
CareDx To Participate in Upcoming Investor Conferences
From CareDx, Inc.
Via Business Wire
CareDx Reports Third Quarter 2022 Results
From CareDx, Inc.
Via Business Wire
CareDx Demonstrates Power of AlloSure and Digital Health Transplant Solutions at American Society of Nephrology Kidney Week
From CareDx, Inc.
Via Business Wire
Independent Longitudinal Study Finds CareDx’s AlloSure Detects Early Signs of Rejection in Pediatric Kidney Transplant Patients
From CareDx, Inc.
Via Business Wire
CareDx Congratulates C-Path's Transplant Therapeutics Consortium and Paris Transplant Group for Receiving EMA Draft Qualification for iBox Scoring System
From CareDx, Inc.
Via Business Wire
CareDx to Report Third Quarter 2022 Financial Results
From CareDx, Inc.
Via Business Wire
CareDx Joins Forces with National Kidney Foundation and Honor the Gift Coalition to Host Immuno Bill Webinar for Kidney Transplant Patients
From CareDx, Inc.
Via Business Wire
CareDx Presents Latest Data on AlloSeq NGS Solutions and Transplant Innovation at the American Society for Histocompatibility and Immunogenetics Annual Meeting
From CareDx, Inc.
Via Business Wire
CareDx to Host Symposium Covering Innovation in Multimodal Surveillance Including AiCAV for Post-Cardiac Transplant Care
From CareDx, Inc.
Via Business Wire
Transplant Patients Experience Less Pain and Fewer Adverse Events with CareDx Non-Invasive Testing Solutions
From CareDx, Inc.
Via Business Wire
CareDx Congratulates Board Member Dr. Grace Colón for Being Named Healthcare Innovator on Top 50 Most Powerful Latinas List
From CareDx, Inc.
Via Business Wire
NASDAQ: CDNA Long Term Investor Alert: Investigation of Potential Wrongdoing at CareDx, Inc
San Diego, CA -- (SBWIRE) -- 09/19/2022 -- Certain directors of CareDx, Inc are under investigation over potential breaches of fiduciary duties by certain directors of CareDx, Inc. 
Via SBWire
CareDx Showcases Transplant Digital Leadership in Patient Care at 2022 MEET Conference
From CareDx, Inc.
Via Business Wire
CareDx Celebrates 1 Million Organ Transplants and 100,000 Patient Milestone
From CareDx, Inc.
Via Business Wire
CareDx Demonstrates Global Leadership at 29th International Congress of The Transplantation Society
From CareDx, Inc.
Via Business Wire
CareDx and MOTTEP Co-Host Health Equity Summit
From CareDx, Inc.
Via Business Wire
CareDx Reports Second Quarter 2022 Results
From CareDx, Inc.
Via Business Wire
CareDx Unveils New Patient-Centered Medication Management Features on AlloCare Mobile Health App
From CareDx, Inc.
Via Business Wire
CareDx Launches Personalized AlloHome Patient Monitoring Solution to Augment Pre- and Post-Transplant Care
From CareDx, Inc.
Via Business Wire
CareDx to Report Second Quarter 2022 Financial Results
From CareDx, Inc.
Via Business Wire
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against CareDx, Inc. (CDNA)
From The Law Offices of Frank R. Cruz
Via Business Wire
CAREDX 48 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against CareDx, Inc. - CDNA
From Kahn Swick & Foti, LLC
Via Business Wire
CAREDX DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against CareDx, Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
Bronstein, Gewirtz & Grossman, LLC Reminds CareDx, Inc. (CDNA) Shareholders of July 22, 2022 Class Action Deadline and Encourages Investors to Actively Participate
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
CDNA SHAREHOLDER ALERT: ROSEN, SKILLED INVESTOR COUNSEL, Encourages CareDx, Inc. Investors with Losses to Secure Counsel Before Important July 22 Deadline in Securities Class Action - CDNA
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Law Enforcement Lawsuit
Exposures Financial Legal
CDNA INVESTOR NOTICE: ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Encourages CareDx, Inc. Investors to Secure Counsel Before Important July 22 Deadline in Securities Class Action - CDNA
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
Topics Law Enforcement Lawsuit
Exposures Financial Legal
Class Action Lawsuit Reminder:  Kessler Topaz Meltzer & Check, LLP Reminds Investors of CareDx, Inc. That A Securities Fraud Class Action Lawsuit Has Been Filed
From KESSLER TOPAZ MELTZER & CHECK, LLP
Via Business Wire
CDNA INVESTOR NOTICE: ROSEN, TRUSTED NATIONAL TRIAL COUNSEL, Encourages CareDx, Inc. Investors with Losses to Secure Counsel Before Important July 22 Deadline in Securities Class Action - CDNA
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
TOP RANKED ROSEN LAW FIRM Encourages CareDx, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - CDNA
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.